| 中文名 | (+)-(3aR,4R,5r,6aS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-4-(3-三氟甲基)苯氧基-1-丁烯基]-2H-环戊并[b]呋喃-2-酮 |
|---|---|
| 英文名 | (3aR,4R,5R,6aS)-5-hydroxy-4-[(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one |
| 中文别名 |
前列腺素杂质24
(+)-(3,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-4-(3-三氟甲基)苯氧基-1-丁烯基]-2H-环戊并[B]呋喃-2-酮 (3,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-4-[3-(三氟甲基)苯氧基]-1-丁烯-1-基]-2H-环戊烷并[B]呋喃-2-酮 2H-环戊并[B]呋喃-2-酮,六氢-5-羟基-4-[(1E,3R)-3-羟基-4-[3-(三氟甲基)苯氧基]-1-丁烯-1-基]-,(3,4R,5R,6AS)-(...) 氟前列醇内酯二醇 曲沃前列素中间体/曲沃前列素杂质 曲沃前列素杂质 曲伏前列素杂质13 Monoclonal Antibody to TERT抗体(别名:TP2 中间体53-9 TERT 多克隆抗体-E-AB-16091 (+)-(3AR,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-4-(3-三氟甲基)苯氧基-1-丁烯基]-2H-环戊并[B]呋喃-2-酮 曲伏前列腺杂质 D 曲沃前列素中间体 |
| 英文别名 |
(3,4R,5R,6aS)-5-Hydroxy-4-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)-phenoxy)but-1-en-1-yl)hexa
(3aR,4R,5R,6aS)-5-Hydroxy-4-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one (3,4R,5R,6aS)-5-Hydroxy-4-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)-phenoxy)but-1-en-1-yl)hexahyd TP-2 Fluprostenone Lactone Diol TCS1 (3,4R,5R,6aS)-5-hydroxy-4-[(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one DKCA2 Travoprost oxide (3aS,4R,5R,6aR)-5-Hydroxy-4-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl}hexahydro-2H-cyclopenta[b]furan-2-one (3,4R,5R,6aS)-5-Hydroxy-4-((R,E)-3-hydroxy-4-(3-(trifluoroMethyl)phenoxy)but-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one Travoprost Intermediate Anti-Telomerase antibody produced in rabbit HYDRIDE-T Travoprost Impurity 13 (3aR,4R,5R,6aS)-5-hydroxy-4-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-enyl)hexahydro-2H-cyclopenta[b]furan-2-one (+)-(3,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-(3-trifluoromethyl)phenoxy-1-butenyl]-2H-cyclopenta[b]furan-2-one(N-3) Curved prostate impurity (3aR,4R,5R,6aS)-5-Hydroxy-4-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl}hexahydro-2H-cyclopenta[b]furan-2-one hTRT (+)-(3,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE 2H-Cyclopenta[b]furan-2-one, hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-, (3,4R,5R,6aS) ravoprost oxide 53-9 (+)-(3,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE CMM9 PFBMFT1 (3,4R,5R,6aS)-4-((R,E)-4-(3-(trifluoromethyl)phenoxy)-3-hydroxybut-1-enyl)-hexahydro-5-hydroxycyclopenta[b]furan-2-one EST2 DKCB4 Anti-TERT antibody produced in goat TP-2 (TV-EDI) (3,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-2-one TP-2 (TV-EDI) (Travoprost) (3aR,4R,5R,6aS)-5-Hydroxy-4-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}hexahydro-2H-cyclopenta[b]furan-2-one Prostaglandin Impurity 24 TV-DI (+)-(3,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3 (+)-FLUPROSTENOL LACTONE DIOL |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 沸点 | 520.6±50.0 °C at 760 mmHg |
| 分子式 | C18H19F3O5 |
| 分子量 | 372.336 |
| 闪点 | 268.6±30.1 °C |
| 精确质量 | 372.118469 |
| PSA | 75.99000 |
| LogP | 1.05 |
| 蒸汽压 | 0.0±1.4 mmHg at 25°C |
| 折射率 | 1.583 |
| 储存条件 | -20°C |
| 危害码 (欧洲) | Xn |
|---|
|
~%
53872-60-9 |
| 文献:WO2011/46569 A1, ; Page/Page column 67-68 ; |
|
~%
53872-60-9 |
| 文献:Journal of Medicinal Chemistry, , vol. 24, # 11 p. 1353 - 1359 |
|
~%
53872-60-9 |
| 文献:Journal of Medicinal Chemistry, , vol. 24, # 11 p. 1353 - 1359 |
|
~%
53872-60-9 |
| 文献:Journal of Medicinal Chemistry, , vol. 24, # 11 p. 1353 - 1359 |
|
~%
53872-60-9 |
| 文献:Journal of Medicinal Chemistry, , vol. 24, # 11 p. 1353 - 1359 |
|
~%
53872-60-9 |
| 文献:WO2013/164729 A1, ; |
| 上游产品 6 | |
|---|---|
| 下游产品 0 | |